Evidence map›Paper›PMID 42840255›Full record

ArticleFrontiers in immunology2026

A multi-epitope vaccine targeting

Pengxiao Feng, Rui Hu, Huanbing Long, Jiarong He, Yuyao Xia, Jizhe Yang, Aihua Lei, Cuiming Zhu

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Pengxiao FengInstitute of Pathogenic Biology, Hengyang Medical College, University of South China, Hunan Provincial Key Laboratory for Special Pathogens Prevention and Control, Hengyang, Hunan, China.
Rui HuInstitute of Pathogenic Biology, Hengyang Medical College, University of South China, Hunan Provincial Key Laboratory for Special Pathogens Prevention and Control, Hengyang, Hunan, China.
Huanbing LongInstitute of Pathogenic Biology, Hengyang Medical College, University of South China, Hunan Provincial Key Laboratory for Special Pathogens Prevention and Control, Hengyang, Hunan, China.
Jiarong HeInstitute of Pathogenic Biology, Hengyang Medical College, University of South China, Hunan Provincial Key Laboratory for Special Pathogens Prevention and Control, Hengyang, Hunan, China.
Yuyao XiaInstitute of Pathogenic Biology, Hengyang Medical College, University of South China, Hunan Provincial Key Laboratory for Special Pathogens Prevention and Control, Hengyang, Hunan, China.
Jizhe YangInstitute of Pathogenic Biology, Hengyang Medical College, University of South China, Hunan Provincial Key Laboratory for Special Pathogens Prevention and Control, Hengyang, Hunan, China.
Aihua LeiInstitute of Pathogenic Biology, Hengyang Medical College, University of South China, Hunan Provincial Key Laboratory for Special Pathogens Prevention and Control, Hengyang, Hunan, China.
Cuiming ZhuInstitute of Pathogenic Biology, Hengyang Medical College, University of South China, Hunan Provincial Key Laboratory for Special Pathogens Prevention and Control, Hengyang, Hunan, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Methods: Immunoinformatics approaches were used to select immunodominant epitopes from the P1 adhesin and the CARDS toxin of Results: P1Tx displayed favorable physicochemical characteristics and structural stability and reacted strongly with sera from Conclusions: P1Tx confers protection against

Indexed as

Adhesins, BacterialBacterial AdhesionBacterial ProteinsBacterial ToxinsBacterial VaccinesMycoplasma pneumoniaePneumonia, MycoplasmaAnimalsAntibodies, BacterialAntibodies, NeutralizingFemaleHumansImmunodominant EpitopesMiceMice, Inbred BALB CProtein Subunit Vaccinesadhesin, Mycoplasma pneumoniaeAdhesins, BacterialAntibodies, BacterialAntibodies, NeutralizingBacterial ProteinsBacterial ToxinsBacterial VaccinesCARDS toxin, Mycoplasma pneumoniaeImmunodominant EpitopesProtein Subunit Vaccinescommunity-acquired respiratory distress syndrome toxinimmune responsemulti-epitope vaccineMycoplasma pneumoniaeP1 adhesin

Identifiers

PMID42840255
PMCPMC13638606

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.